Media-OutReach Newswire China Dongxiang Announces Interim Results for the First Half of 2018 Reforms Continued with High Dividend Payout Maintained
Media-OutReach Newswire The Buck Institute, Insilico Medicine, and Juvenescence Found Napa Therapeutics to Develop Drugs to Impede Age-Related Disease
Media-OutReach Newswire Sihuan Pharmaceutical’s Self-Developed Innovative Oncology Drug Pirotinib Commenced Phase II Clinical Trial in China